gallic acid has been researched along with Cancer of Lung in 31 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lung adenomas were induced in strain A mice by chronic treatment with N-nitroso compounds (given in drinking water) and with amines or ureas in food plus NaNO2 in drinking water." | 7.65 | Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: effect of ascorbate, gallic acid, thiocyanate, and caffeine. ( Cardesa, A; Mirvish, SS; Shubik, P; Wallcave, L, 1975) |
| "Gallic acid reduced the viability of Malignant Mesothelioma cells in a concentration and time-dependent manner." | 5.43 | EGFR-dependent signalling reduced and p38 dependent apoptosis required by Gallic acid in Malignant Mesothelioma cells. ( Ayvali, N; Candemir, G; Demiroglu-Zergeroglu, A; Sagir, F; Turhanlar, E, 2016) |
| "Although multiple studies have revealed that gallic acid plays an important role in the inhibition of malignant transformation, cancer development, and inflammation, the molecular mechanism of gallic acid in inflammatory diseases is still unclear." | 3.75 | Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. ( Choi, KC; Jun, WJ; Jung, MG; Kim, MJ; Kwon, SH; Lee, J; Lee, JM; Lee, YH; Yoon, HG, 2009) |
| "The apoptosis-inducing effect of gallic acid (3,4,5-trihydroxybenzoic acid) was investigated in four human lung cancer cell lines, SBC-3 (small cell carcinoma), EBC-1 (squamous cell carcinoma), A549 (adenocarcinoma) and SBC-3/CDDP (cisplatin-resistant subclone of SBC-3)." | 3.70 | Induction of apoptosis by gallic acid in lung cancer cells. ( Akao, S; Fujiwara, H; Fujiwara, T; Fukuda, K; Gotou, K; Maruyama, R; Ohno, Y; Takemura, G; Toyota, M; Watanabe, M; Xinbin, Q; Yasuda, N, 1999) |
| "Lung adenomas were induced in strain A mice by chronic treatment with N-nitroso compounds (given in drinking water) and with amines or ureas in food plus NaNO2 in drinking water." | 3.65 | Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: effect of ascorbate, gallic acid, thiocyanate, and caffeine. ( Cardesa, A; Mirvish, SS; Shubik, P; Wallcave, L, 1975) |
| "Lung cancer is one of the most aggressive forms of cancer that leads to a high mortality rate amongst several cancer types and it is a widely recurrent cancer globally." | 1.56 | Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer. ( Qi, L; Qiu, F; Yang, N; Zhu, F, 2020) |
| "Metastasis is the main cause of cancer-related death and requires the development of effective treatments with reduced toxicity and effective anticancer activity." | 1.46 | Solid lipid nanoparticles improve octyl gallate antimetastatic activity and ameliorate its renal and hepatic toxic effects. ( Cordova, CAS; Creczynski-Pasa, TB; Jasper, R; Locatelli, C; Mascarello, A; Nunes, RJ; Silva, AH; Winter, E; Yunes, RA; Zanetti-Ramos, BG, 2017) |
| "Lung cancer is one of the most of cancer type founds and a leading cause of death worldwide." | 1.46 | Nanogold-Gallate Chitosan-Targeted Pulmonary Delivery for Treatment of Lung Cancer. ( Ekgasit, S; Komenek, S; Luesakul, U; Muangsin, N; Praphairaksit, N; Puthong, S; Vilaivan, T, 2017) |
| "Treatment with gallic acid resulted in a significant reduction in proliferation and induction of apoptosis, only in EGFR-mutant NSCLC cells." | 1.43 | Gallic acid induces apoptosis in EGFR-mutant non-small cell lung cancers by accelerating EGFR turnover. ( Nam, B; Rho, JK; Shin, DM; Son, J, 2016) |
| "Gallic acid reduced the viability of Malignant Mesothelioma cells in a concentration and time-dependent manner." | 1.43 | EGFR-dependent signalling reduced and p38 dependent apoptosis required by Gallic acid in Malignant Mesothelioma cells. ( Ayvali, N; Candemir, G; Demiroglu-Zergeroglu, A; Sagir, F; Turhanlar, E, 2016) |
| " It was observed that C(14) decreased lung metastasis in vivo by 80% and increased the survival rate of the animals without toxic effects." | 1.38 | Antimetastatic activity and low systemic toxicity of tetradecyl gallate in a preclinical melanoma mouse model. ( Carvalho, DR; Creczynski-Pasa, TB; de Cordova, CA; Locatelli, C; Mascarello, A; Nunes, RJ; Pilati, C; Yunes, RA, 2012) |
| " From this active fraction, seven compounds have been isolated and four compounds (pinosylvin, galangin, quercetin and methyl gallate) have been examined for their dose-response effect on the viability of A549 cells and on TNF-α inhibitory activity." | 1.37 | Bioactivity guided isolation of anticancer constituents from leaves of Alnus sieboldiana (Betulaceae). ( Asakawa, Y; Kuzuhara, T; Ludwiczuk, A; Saha, A, 2011) |
| "We utilized two tumoral models: Ehrlich ascites tumor cells (EAT)/BALB/c mice and Lewis lung cancer cells (LLC1)/C57bl/6 mice." | 1.35 | Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae). ( Chaar, Jda S; Da Silva, SL; Yano, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 5 (16.13) | 29.6817 |
| 2010's | 19 (61.29) | 24.3611 |
| 2020's | 4 (12.90) | 2.80 |
| Authors | Studies |
|---|---|
| Nam, B | 1 |
| Rho, JK | 2 |
| Shin, DM | 1 |
| Son, J | 1 |
| Yadav, DK | 1 |
| Bhadresha, K | 1 |
| Rao, P | 1 |
| Shaikh, S | 1 |
| Rawal, RM | 1 |
| Tan, YJ | 1 |
| Ali, A | 1 |
| Tee, SY | 1 |
| Teo, JT | 1 |
| Xi, Y | 1 |
| Go, ML | 1 |
| Lam, Y | 1 |
| Gupta, N | 1 |
| Bhagat, S | 1 |
| Singh, M | 1 |
| Jangid, AK | 1 |
| Bansal, V | 1 |
| Singh, S | 1 |
| Pooja, D | 1 |
| Kulhari, H | 1 |
| Wang, D | 1 |
| Bao, B | 1 |
| Yang, N | 1 |
| Qiu, F | 1 |
| Zhu, F | 1 |
| Qi, L | 1 |
| Cordova, CAS | 1 |
| Locatelli, C | 2 |
| Winter, E | 1 |
| Silva, AH | 1 |
| Zanetti-Ramos, BG | 1 |
| Jasper, R | 1 |
| Mascarello, A | 2 |
| Yunes, RA | 2 |
| Nunes, RJ | 2 |
| Creczynski-Pasa, TB | 2 |
| Maimaiti, A | 1 |
| Aili, A | 1 |
| Kuerban, H | 1 |
| Li, X | 1 |
| Sunil Gowda, SN | 1 |
| Rajasowmiya, S | 1 |
| Vadivel, V | 1 |
| Banu Devi, S | 1 |
| Celestin Jerald, A | 1 |
| Marimuthu, S | 1 |
| Devipriya, N | 1 |
| Zhang, T | 1 |
| Ma, L | 2 |
| Wu, P | 1 |
| Li, W | 2 |
| Li, T | 1 |
| Gu, R | 1 |
| Dan, X | 1 |
| Li, Z | 1 |
| Fan, X | 1 |
| Xiao, Z | 1 |
| Park, WH | 3 |
| Kim, SH | 2 |
| Gao, Y | 1 |
| Jia, L | 1 |
| Li, B | 1 |
| Chen, YC | 1 |
| Tu, Y | 1 |
| Jin, P | 1 |
| Zhu, FX | 1 |
| Tan, XB | 1 |
| Liu, WB | 1 |
| Jin, X | 1 |
| Feng, L | 1 |
| Jia, XB | 1 |
| Mao, F | 1 |
| Zhang, L | 1 |
| Cai, MH | 1 |
| Guo, H | 1 |
| Yuan, HH | 1 |
| Park, J | 1 |
| Shim, MK | 1 |
| Jin, M | 1 |
| Rhyu, MR | 1 |
| Lee, Y | 1 |
| Wang, R | 1 |
| Weng, D | 1 |
| Yao, J | 1 |
| Liu, X | 1 |
| Jin, F | 1 |
| Phan, AN | 1 |
| Hua, TN | 1 |
| Kim, MK | 1 |
| Vo, VT | 1 |
| Choi, JW | 1 |
| Kim, HW | 1 |
| Kim, KW | 1 |
| Jeong, Y | 1 |
| Komenek, S | 1 |
| Luesakul, U | 1 |
| Ekgasit, S | 1 |
| Vilaivan, T | 1 |
| Praphairaksit, N | 1 |
| Puthong, S | 1 |
| Muangsin, N | 1 |
| Demiroglu-Zergeroglu, A | 1 |
| Candemir, G | 1 |
| Turhanlar, E | 1 |
| Sagir, F | 1 |
| Ayvali, N | 1 |
| Da Silva, SL | 1 |
| Chaar, Jda S | 1 |
| Yano, T | 1 |
| Park, YS | 1 |
| Towantakavanit, K | 1 |
| Kowalska, T | 1 |
| Jung, ST | 1 |
| Ham, KS | 1 |
| Heo, BG | 1 |
| Cho, JY | 1 |
| Yun, JG | 1 |
| Kim, HJ | 1 |
| Gorinstein, S | 1 |
| Choi, KC | 1 |
| Lee, YH | 1 |
| Jung, MG | 1 |
| Kwon, SH | 1 |
| Kim, MJ | 1 |
| Jun, WJ | 1 |
| Lee, J | 1 |
| Lee, JM | 1 |
| Yoon, HG | 1 |
| Ji, BC | 1 |
| Hsu, WH | 1 |
| Yang, JS | 1 |
| Hsia, TC | 1 |
| Lu, CC | 1 |
| Chiang, JH | 1 |
| Yang, JL | 1 |
| Lin, CH | 1 |
| Lin, JJ | 1 |
| Suen, LJ | 1 |
| Gibson Wood, W | 1 |
| Chung, JG | 1 |
| You, BR | 2 |
| Ludwiczuk, A | 1 |
| Saha, A | 1 |
| Kuzuhara, T | 1 |
| Asakawa, Y | 1 |
| Carvalho, DR | 1 |
| de Cordova, CA | 1 |
| Pilati, C | 1 |
| Kim, SZ | 1 |
| Sazuka, M | 1 |
| Imazawa, H | 1 |
| Shoji, Y | 1 |
| Mita, T | 1 |
| Hara, Y | 1 |
| Isemura, M | 1 |
| Ohno, Y | 2 |
| Fukuda, K | 2 |
| Takemura, G | 2 |
| Toyota, M | 1 |
| Watanabe, M | 2 |
| Yasuda, N | 2 |
| Xinbin, Q | 1 |
| Maruyama, R | 1 |
| Akao, S | 2 |
| Gotou, K | 1 |
| Fujiwara, T | 1 |
| Fujiwara, H | 2 |
| Kawada, M | 1 |
| Ri, Y | 1 |
| Ikoma, T | 1 |
| Yuugetu, H | 1 |
| Asai, T | 1 |
| Minatoguchi, S | 1 |
| Gotoh, K | 1 |
| Mirvish, SS | 1 |
| Cardesa, A | 1 |
| Wallcave, L | 1 |
| Shubik, P | 1 |
31 other studies available for gallic acid and Cancer of Lung
| Article | Year |
|---|---|
Gallic acid induces apoptosis in EGFR-mutant non-small cell lung cancers by accelerating EGFR turnover.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Gallic Acid; Humans; Lu | 2016 |
Identification of hub genes associated with prognosis of lung cancer via integrated bioinformatics and
Topics: Biomarkers, Tumor; Computational Biology; Female; Gallic Acid; Gene Expression Profiling; Gene Expre | 2023 |
Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Su | 2019 |
Site-specific delivery of a natural chemotherapeutic agent to human lung cancer cells using biotinylated 2D rGO nanocarriers.
Topics: A549 Cells; Antineoplastic Agents; Biotinylation; Cell Survival; Coumarins; Drug Carriers; Endocytos | 2020 |
Gallic Acid Impedes Non-Small Cell Lung Cancer Progression via Suppression of EGFR-Dependent CARM1-PELP1 Complex.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; CARD Signaling Adaptor Proteins; Cell Movemen | 2020 |
Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzo(a)pyrene; Female; Gallic Ac | 2020 |
Solid lipid nanoparticles improve octyl gallate antimetastatic activity and ameliorate its renal and hepatic toxic effects.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chlorocebus aethiops; Female; Gallic Acid; Kidney D | 2017 |
VDAC1 Mediated Anticancer Activity of Gallic Acid in Human Lung Adenocarcinoma A549 Cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-R | 2018 |
Gallic acid-coated sliver nanoparticle alters the expression of radiation-induced epithelial-mesenchymal transition in non-small lung cancer cells.
Topics: A549 Cells; Antigens, CD; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Survival; Epithelial-Mesen | 2018 |
Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell | 2019 |
MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Gallic Acid; Glutathione; Humans; JNK Mitogen-Activ | 2013 |
Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Ascorbic Acid; Biflavonoi | 2013 |
[Study on effective substances of tea for chemoprevention of lung cancer based on principal component analysis].
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Bronchi; Catechin; Cell Survival; Cells, | 2013 |
Leonurine hydrochloride induces apoptosis of H292 lung cancer cell by a mitochondria-dependent pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gallic Acid; Huma | 2015 |
Methyl syringate, a TRPA1 agonist represses hypoxia-induced cyclooxygenase-2 in lung cancer cells.
Topics: Calcium Channels; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Epithelial Cells; | 2016 |
Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cell | 2016 |
Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors | 2016 |
Nanogold-Gallate Chitosan-Targeted Pulmonary Delivery for Treatment of Lung Cancer.
Topics: Antineoplastic Agents; Biocompatible Materials; Chitosan; Cisplatin; Drug Delivery Systems; Excipien | 2017 |
EGFR-dependent signalling reduced and p38 dependent apoptosis required by Gallic acid in Malignant Mesothelioma cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; ErbB Receptors; Gallic Acid; Humans; Lung Neoplasms; Mes | 2016 |
Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Carcinoma, Lewis Lung; Caseari | 2009 |
Bioactive compounds and antioxidant and antiproliferative activities of Korean white lotus cultivars.
Topics: Amino Acids; Antineoplastic Agents, Phytogenic; Antioxidants; Ascorbic Acid; Cell Line, Tumor; Cell | 2009 |
Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells.
Topics: Acetylation; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; E1A-Associated p300 Protein; Enzym | 2009 |
Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo.
Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; | 2009 |
Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase.
Topics: Acetylcysteine; Antineoplastic Agents; Ascorbic Acid; Buthionine Sulfoximine; Cell Death; Cell Line, | 2010 |
Bioactivity guided isolation of anticancer constituents from leaves of Alnus sieboldiana (Betulaceae).
Topics: Alnus; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Dose-Response R | 2011 |
Antimetastatic activity and low systemic toxicity of tetradecyl gallate in a preclinical melanoma mouse model.
Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Survival; Female; Gallic Acid; Intercellular Adh | 2012 |
Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion.
Topics: Apoptosis; Caspase Inhibitors; Cell Line, Tumor; Fibroblasts; Gallic Acid; Glutathione; Humans; Lung | 2011 |
Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins.
Topics: Animals; Antioxidants; Biflavonoids; Carcinoma; Catechin; Free Radical Scavengers; Gallic Acid; Lung | 1997 |
Induction of apoptosis by gallic acid in lung cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Carcinoma, Small Cell; Carcinoma, Squamous Cell; C | 1999 |
Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Cisplatin; DNA, N | 2001 |
Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: effect of ascorbate, gallic acid, thiocyanate, and caffeine.
Topics: Adenoma; Amines; Animals; Ascorbic Acid; Caffeine; Dose-Response Relationship, Drug; Gallic Acid; Lu | 1975 |